BeiGene Opens New Jersey-Based Biologics Manufacturing and Clinical R&D Site
BeiGene has opened its new $800 million Hopewell, NJ-based biologics manufacturing facility, which also houses the company's clinical R&D capabilities. Editor's note: this story was originally published on BioPharmInternational.com. Oncology …